+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
From
From
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
ALK Positive Non-Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

ALK Positive Non-Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
EGFR Non-Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

EGFR Non-Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
From
From
From
From
From
From
Hemophagocytic Lymphohistiocytosis - Pipeline Insight, 2024 - Product Thumbnail Image

Hemophagocytic Lymphohistiocytosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Collagen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Collagen inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Advanced Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more